| 注册
首页|期刊导航|新医学|更年期综合征诊治现状及星状神经节阻滞在其中的应用

更年期综合征诊治现状及星状神经节阻滞在其中的应用

邢纪斌 李响 程楠 方莉 周少丽

新医学2025,Vol.56Issue(7):663-669,7.
新医学2025,Vol.56Issue(7):663-669,7.DOI:10.12464/j.issn.0253-9802.2024-0313

更年期综合征诊治现状及星状神经节阻滞在其中的应用

Current status of diagnosis and treatment of menopausal syndrome and the application of stellate ganglion block

邢纪斌 1李响 1程楠 1方莉 2周少丽1

作者信息

  • 1. 中山大学附属第三医院睡眠医学中心神经阻滞与疼痛治疗分部,广东 广州 510630
  • 2. 中山大学附属第三医院妇科,广东 广州 510630
  • 折叠

摘要

Abstract

Menopausal syndrome has a high incidence rate and significantly impacts women's physical and mental health.Its exact pathogenesis remains unclear,but it is generally believed that hormonal changes during menopause are the primary cause of multisystem symptoms and systemic discomfort.Currently,hormone replacement therapy(HRT)is the main treatment for menopausal syndrome;however,HRT is not suitable for all menopausal patients.Recent studies have shown that HRT may increase the risk of coronary atherosclerotic heart disease,stroke,and breast cancer.Stellate ganglion block(SGB),by modulating the sympathetic neural network,exerts inhibitory effects on excessive stress responses,anti-inflammatory and analgesic actions,and promotes neural function recovery,making it widely applicable in pain treatment and related fields.With the progressive advancement of research on SGB applications,increasing evidence suggests that SGB plays an important role in the treatment of menopausal syndrome.This article reviews the epidemiology,pathogenesis,diagnosis and treatment methods of menopausal syndrome,with a particular focus on the potential therapeutic role of SGB,which aims to provide new insights for research on menopausal syndrome treatment.

关键词

更年期综合征/星状神经节阻滞/神经调控/麻醉治疗学

Key words

Menopausal syndrome/Stellate ganglion block/Neuromodulation/Anesthetic therapeutics

引用本文复制引用

邢纪斌,李响,程楠,方莉,周少丽..更年期综合征诊治现状及星状神经节阻滞在其中的应用[J].新医学,2025,56(7):663-669,7.

基金项目

广东省基础与应用基础研究基金企业联合基金(2021A1515220061) (2021A1515220061)

广东省医学会偏向性激动剂-新型阿片类镇痛药物医学研究项目专项基金(GDMA 2024098002) (GDMA 2024098002)

中山大学附属第三医院临床研究专项基金(YHJH202307) (YHJH202307)

新医学

0253-9802

访问量0
|
下载量0
段落导航相关论文